UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 222

Sortiert nach

Molecularly targeted therapies for metastatic triple-negative breast cancer

Breast cancer research and treatment, 2013-02, Vol.138 (1), p.21-35

2013

Volltextzugriff (PDF)

Frequency and Vehicle Capacity Determination using a Dynamic Transit Assignment Model

Transportation research record, 2019-03, Vol.2673 (3), p.574-585

2019

Volltextzugriff (PDF)

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

Breast cancer research and treatment, 2013-06, Vol.139 (3), p.759-767

2013

Volltextzugriff (PDF)

Participation in Cancer Clinical Trials: Why Are Patients Not Participating?

Medical decision making, 2014-01, Vol.34 (1), p.116-126

2014

Volltextzugriff (PDF)

Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer

Clinical breast cancer, 2017-04, Vol.17 (2), p.79-90

Glück, Stefan, MD, PhD, FRCPC

2017

Volltextzugriff (PDF)

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.781-791

2012

Volltextzugriff (PDF)

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians

Breast cancer research and treatment, 2016-07, Vol.158 (1), p.113-126

2016

Volltextzugriff (PDF)

A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.747-751

2012

Volltextzugriff (PDF)

Future perspectives and challenges with CDK4/6 inhibitors in hormone receptor–positive metastatic breast cancer

Future oncology (London, England), 2020-11, Vol.16 (32), p.2661-2672

2020

Volltextzugriff (PDF)

How Stress Management Improves Quality of Life After Treatment for Breast Cancer

Journal of consulting and clinical psychology, 2006-12, Vol.74 (6), p.1143-1152

2006

Volltextzugriff (PDF)

How Stress Management Improves Quality of Life After Treatment for Breast Cancer

Journal of consulting and clinical psychology, 2006-12, Vol.74 (6), p.1143-1152

2006

Volltextzugriff (PDF)

Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)

Contemporary clinical trials, 2018-08, Vol.71, p.194-198

2018

Volltextzugriff (PDF)

Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up

General hospital psychiatry, 2017-01, Vol.44, p.16-21

2017

Volltextzugriff (PDF)

A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer

Breast cancer research and treatment, 2013, Vol.137 (1), p.187-193

2013

Volltextzugriff (PDF)

Stress management intervention reduces serum cortisol and increases relaxation during treatment for nonmetastatic breast cancer

Psychosomatic medicine, 2008-11, Vol.70 (9), p.1044-1049

2008

Volltextzugriff (PDF)

Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?

Breast cancer research and treatment, 2014-11, Vol.148 (1), p.117-123

2014

Volltextzugriff (PDF)

Introduction to special issue Translational goals of neoadjuvant therapy

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.773-773

Gluck, Stefan

2012

Volltextzugriff (PDF)

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Breast cancer research and treatment, 2010-09, Vol.123 (2), p.427-435

2010

Volltextzugriff (PDF)

Randomized Controlled Trial of Cognitive Behavioral Stress Management in Breast Cancer: A Brief Report of Effects on 5-Year Depressive Symptoms

Health psychology, 2015-02, Vol.34 (2), p.176-180

2015

Volltextzugriff (PDF)

Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting

Clinical therapeutics, 2015-01, Vol.37 (1), p.134-144

2015

Volltextzugriff (PDF)

The Prevention and Management of Distant Metastases in Women with Breast Cancer

Cancer investigation, 2007-01, Vol.25 (1), p.6-13

Glück, Stefan

2007

Volltextzugriff (PDF)

Comparative effectiveness of early-line nab -paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Cancer management and research, 2018-01, Vol.10, p.249-256

2018

Volltextzugriff (PDF)

Systemic therapy options in BRCA mutation-associated breast cancer

Breast cancer research and treatment, 2012-09, Vol.135 (2), p.355-366

2012

Volltextzugriff (PDF)

Ethnic differences in types of social support from multiple sources after breast cancer surgery

Ethnicity & health, 2016-10, Vol.21 (5), p.411-425

2016

Volltextzugriff (PDF)

A Woman's Heart : The Impact of Adjuvant Endocrine Therapy on Cardiovascular Health

Cancer, 2009-05, Vol.115 (9), p.1813-1826

2009

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(195)

Publikationsform

Sprache

Englisch
(215)
Japanisch
(17)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(118)
Humans
(115)
Female
(97)
Oncology
(66)
Breast Cancer
(59)
Middle Aged
(58)
Adult
(48)
Breast Neoplasms - Drug Therapy
(45)
Aged
(43)
Breast Neoplasms - Pathology
(38)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(30)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Chemotherapy
(29)
Male
(26)
Medicine
(25)
Medicine & Public Health
(25)
Cancer Therapies
(22)
Treatment Outcome
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecularly targeted therapies for metastatic triple-negative breast cancer

Frequency and Vehicle Capacity Determination using a Dynamic Transit Assignment Model

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

Participation in Cancer Clinical Trials: Why Are Patients Not Participating?

Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians

A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer

Future perspectives and challenges with CDK4/6 inhibitors in hormone receptor–positive metastatic breast cancer

How Stress Management Improves Quality of Life After Treatment for Breast Cancer

How Stress Management Improves Quality of Life After Treatment for Breast Cancer

Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)

Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up

A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer

Stress management intervention reduces serum cortisol and increases relaxation during treatment for nonmetastatic breast cancer

Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?

Introduction to special issue Translational goals of neoadjuvant therapy

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Randomized Controlled Trial of Cognitive Behavioral Stress Management in Breast Cancer: A Brief Report of Effects on 5-Year Depressive Symptoms

Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting

The Prevention and Management of Distant Metastases in Women with Breast Cancer

Comparative effectiveness of early-line nab -paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Systemic therapy options in BRCA mutation-associated breast cancer

Ethnic differences in types of social support from multiple sources after breast cancer surgery

A Woman's Heart : The Impact of Adjuvant Endocrine Therapy on Cardiovascular Health

Suchergebnisse filtern